lundi 19 juillet 2021

How an Unproven Alzheimer’s Drug Got Approved

Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.

from NYT > Health https://ift.tt/3imHC2y
via health&fitness

Aucun commentaire:

Enregistrer un commentaire